Jennerex Biotherapeutics' Series E - III Round

Jennerex Biotherapeutics raised a round of funding on October 13, 2011. Investors include Skypoint Capital.

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead produ…

Articles about Jennerex Biotherapeutics' Series E - III Round: